Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-09
1999-12-14
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514266, 514262, 514261, 514267, 514352, 514271, 514272, A61K 3152, A61K 31505, A61K 31515
Patent
active
060018429
ABSTRACT:
Methods of preventing or treating ischemia-reperfusion injury in an organ by administration of a composition containing a selective A.sub.1 adenosine receptor antagonist and/or a P.sub.2X purinoceptor antagonist are provided. Methods of preventing or treating endotoxin-related tissue injury by administration of a composition containing a selective A.sub.1 adenosine receptor antagonist and/or a P.sub.2X purinoceptor antagonist are also provided.
REFERENCES:
patent: 4772607 (1988-09-01), Badger et al.
patent: 4783530 (1988-11-01), Rzeszotarski et al.
patent: 4968672 (1990-11-01), Jacobson et al.
patent: 5032593 (1991-07-01), Rzeszotarski et al.
patent: 5175290 (1992-12-01), Rzeszotarski et al.
patent: 5248678 (1993-09-01), Costa et al.
patent: 5366977 (1994-11-01), Pollard et al.
patent: 5504090 (1996-04-01), Neely
patent: 5733916 (1998-03-01), Neely
patent: 5773306 (1998-06-01), Neely
patent: 5786360 (1998-07-01), Neely
Adkins et al., "Adenosine Prevents PMA-induced Lung Injury Via an A2 Receptor Mechanism" Appl. Physiol., 1993, 74(3):982-988.
Abbracchio MP and Burnstock G, "Purinoceptors: Are There Families of P2X and P2Y Purinoceptors?" Pharmac. Ther. 64:445-475, 1994.
Arai M, et al., "An experimental study on the severe type of alcoholic liver disease--a pathogenetic role of potentiated activation of complement system of endotoxin after chronic ethanol consumption", Jap. J. Gastroenterology 86:1089-1095, 1989.
Abel-Aziz MT et al., "Role of Endotoxin in Liver Injury", J. Clin. Biochem. Nutr. 22:19-29, 1997.
Adkins et al., "Adenosine Prevents PMA-induced Lung Injury Via an A2 Receptor Mechanism", Appl. Physiol. 74(3):982-988, 1993.
Behar, Cohen FF, et al., "Iontophoresis of Dexamenthasone in the Treatment of Endotoxin-Induced-Uvetis in Rats", Exp. Eye Res. 65:533-545, 1997.
Bo, X. and Burnstock, G., "Heterogeneous Distribution of .sup.3 H.alpha.,.beta.-Methylene ATP Binding Sites in Blood Vessels" J. Vas. Res. 30:87-101, 1993.
Berger D, et al., "Determination of Endotoxin-Neutralizing Capacity of Plasma in Postsurgical Patients", E. Surg. Res. 28:130-139, 1996.
Bultmann R. et al., "P.sub.2 -purinoceptor antagonists: I. Blockade of P.sub.2 -purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates", Naunyn-Schmied. Arch. Pharmacol. 354:481-490, 1996.
Bultmann R, et al. "P.sub.2 -purinoceptor anatagonists: III. Blockade by P.sub.2 -purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin", Naunyn-Schmied. Arch. Pharmacol. 354:498-504, 1996.
Burnstock G, "Cholinergic and Purinergic Regulation of Blood Vessels" Handbook of Physiology--The Cardiovascular System II, 2nd Edition, vol. 2, Chapter 19, pp. 567-612, 1979.
Burnstock, G. and Kennedy, C., "Is There A Basis For Distinguishing Two Types of P.sub.2 -Purinoceptor?" Gen. Pharmac. 16:433-440, 1985.
Burnstock, G. and Warland, J.J.I., "P.sub.2 -purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P.sub.2y - but not the P.sub.2x -purinoceptor" Br. J. Pharmacol. 90:383-391, 1987.
Berti et al., "Pharmacological Activity of Bamifylline On Lung Anaphylaxis: In Vitro Studies", Pharmacol. Res. 22:143-150, 1990.
Berti et al. "New Pharmacological Data on the Bronchospasmolytic Activity of Bamifylline", Arzneum Forsch/Drug Res. 38:40-44, 1988.
Cronstein BN, et al., "Adenosine Modulates the Generation of Superoxide Anion by Stimulated Human Neutrophils via Interaction with a Specific Cell Surface Receptor" Ann NY Acad Sci 451:291-301, 1985.
Drury AN, Szent-Gyorgi A, "The Physiological Activity of Adenine Compounds.sup.1 with Especial Reference To Their Action Upon The Mammalian Heart", J. Physiol (Lond) 68:213-237, 1929.
Duffy LC, et al. "Concordance of bacterial Cultures with Endotoxin and Interleukin-6 inNecrotizing Enterocolitis", Digestive Dis. and Sci. 42:359-365, 1997.
Egan TM, et al., "Lung transplantation", Curr Probl Surg 26:675-751, 1989.
Ely, SW et al., "Functional and Metabolic Evidence of Enhanced Myocardial Tolerance to Ischemia and Reperfusion with Adenosine" J. Thorac Cardiovasc Surg 90:549-556, 1985.
Ely SW, Berne RM, "Protective Effects of Adenosine in Myocardial Ischemia" Circ 85:893-904, 1992.
Goddard CM, et al., "Myocardial morphometric changes related to decreased contractility after endotoxin", Am. J. Physiol. 270:H1446-H1452, 1996.
Hazan Y, et al., "The diagnostic value of amniotic fluid Gram stain examination and limulus amebocyte lysate assay in patients with preterm birth", Acta Obstet. Gynecol. Scand. 74:275-280, 1995.
Hurley JC and Tosolini FA, "A quantitative micro-assay for endotoxin and correlation with baterial density in urine", J. Microbiol. Methods 16:91-99, 1992.
Haselton FR et al., "Adenosine Decreases Permeability of In Vitro Endothelial Monolayers", J Appl Physiol 74:1581-1590, 1993.
Herbert JM, et al. "Hypoxia Primes Endotoxin-Induced Tissue Factor Expression in Human Monocytes and Endothelial Cells by a PAF-Dependent Mechanism", J. Cellular Physiol. 169:290-299, 1996.
Hopwood, A.M. and Burnstock, G., "ATP mediates coronary vasoconstriction via P.sub.2x -purinoceptors and coronary vasodilation via P.sub.2y -purinoceptors in the isloated perfused rat heart", E. J. Pharmacol. 136:49-54, 1987.
Hamvas A, et al., "Inflammation and Oxygen Free Radical Formation During Pulmonary Ischemia-reperfusion Injury", J Appl Physiol 72:621-628, 1992.
Humphrey PPA, et al., "New insights on P.sup.2x purinoceptors", Naunyn-Schmied. Arch. Pharmacol. 352:585-596, 1995.
Houston et al. "Different P.sub.2 -Purinergic Receptor Subtypes of Endothelium and Smooth Muscle in Canine Blood Vessels", J. Pharmacol. Exp. Ther. 241:501-506, 1987.
Hourani SMO, Cusack NJ, Actions and Structure Activity Relationships of Purines on Platelets. In Purines. Pharmacology and Physiological Roles. Edited by TW Stone, VCH, London, pp. 163-173, 1985.
Hoyle, C.H.V., "Pharmacological Activity of Adenine Dinucleotides in the Periphery: Possible Receptor Classes and Transmitter Function", Gen. Pharmac. 21:827-831, 1990.
Hoyle, C.H.V., "Isolated human bladder: evidence for an adenine dinucleotide acting on P.sub.2x -purinoceptors and for purinergic transmission", E. J. Pharmacol. 174:115-118, 1989.
Ishazaki M, et al., "Usefulness of the Endotoxin Test for Assessing CAPD Peritonitis by Gram-Negative Organisms", Advances in Peritoneal Dialysis 12:199-202, 1996.
Janier, MF, et al., "Adenosine Protects Ischemic and Reperfused Myocardium by Receptor-Mediated Mechanisms", Am J Physiol 264:H163-H170, 1993.
Kellett, R. et al., "Amelioration of Glycerol-Induced Acute Renal Failure in the Rat with 8-cyclopentyl-1, 3-dipropylxanthine", Br. J. Pharmacol., 98:1066-1074, 1989.
Knight, R.J., et al., "Effect of the Selective A.sub.1 Adenosine Antagonist 8-cyclopentyl-1, 3-dipropylxanthine on Acute Renal Dysfunction Induced by Escherichia coli Endotoxin in Rats", J. Pharm. Pharmacol., 45:979-984, 1993.
Kuratani T, et al., "Experimental Study in a Rabbit Model of Ischemia-reperfusion Lung Injury During Cardiopulmonary Bypass", J Thorac Cardiovas Surg 103:564-568, 1992.
Lasley, RD, et al., "Adenosine Improves Recovery of Postischemic Myocardial Function Via an Adenosine A.sub.1 Receptor Mechanism", Am J Physiol 263:H1460-H1465, 1992.
Liu et al. "Characterization and Disbrituon of P.sub.2 -Purinoceptor Subtypes in Rat Pulmonary Vessels", J. Pharmacol. Exp. Ther. 251:1204-1210, 1989.
Lui GS, et al., "Protection Against Infarction Afforded by Preconditioning is Mediated by A.sub.1 Adenosine Receptors in Rabbit Heart", Circ 84:350-356, 1991.
Lew WY, et al., "Lipopolysaccharide induces cell shrinkage in rabbit ventricular cardiac myocytes", Am. J. Physiol. 272:H2989-H2993, 1997.
Lambrecht et al., "PPADS, a novel functionally selective antagonist of P.sub.2 purinoceptor-mediated responses", E. J. Pharmacol. 217:217-219, 1992.
Levinson RM, et al., "Reperfusion Pulmonary Edema After Pulmonary Artery Thromboendarterectomy", Am Rev Resp Dis 134:1241-1245, 1986.
Liu, P, et al., "Priming of Phagocytes for Reactive Oxygen Production During Hepatic Ischemia-Repe
Lambkin Deborah C.
Trustees of the University of Pennsylvania
LandOfFree
Compositions and methods for use in ischemia-reperfusion and end does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for use in ischemia-reperfusion and end, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for use in ischemia-reperfusion and end will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863685